MOVE

MOVE INC COM STK NEW (DE)

MOVE

Delisted

MOVE was delisted on the 13th of November, 2014.

Back to rankings

Real Estate Real Estate Services

Financial journalist opinion

Movano Health Granted Listing Extension by Nasdaq

PLEASANTON, Calif. , Aug. 28, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE )(the "Company") announced today that, by letter received on August 27, 2025, the Nasdaq Hearings Panel (the "Panel") of The Nasdaq Stock Market LLC ("Nasdaq") has determined to grant the Company's request to continue its listing on Nasdaq, subject to (i) the Company regaining compliance with Listing Rule 5250(c)(1), requiring the timely filing of periodic reports (the "Period Filing Rule"), by filing its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025 on or before September 30, 2025, and (ii) the Company demonstrating compliance with Listing Rule 5550(a)(2), requiring the maintenance of $1.00 per share bid price (the "Bid Price Rule"), on or before October 30, 2025.

Movano Health Granted Listing Extension by Nasdaq

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PLEASANTON, Calif. , Aug. 22, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE )(the "Company") announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended June 30, 2025 (the "Form 10-Q"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Filing Requirement") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the "SEC").

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel

Received Delisting Notice from Nasdaq Related to Minimum Bid Price Requirement and Late Filing of the Form 10-Q for the period ended March 31, 2025 PLEASANTON, Calif. , July 11, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) (the "Company") announced today that, on July 7, 2025, it received a delisting determination from The Nasdaq Capital Market with respect to the $1.00 per share bid price requirement (the "Bid Price Requirement"), as set forth in Listing Rule 5550(a)(2), and the late filing requirement, as set forth in Listing Rule 5250(c)(1), given the delay in filing its Form 10-Q for the quarter ended March 31, 2025 (the "Filing Requirement")(together, the "Notice").

Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PLEASANTON, Calif. , May 23, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE )(the "Company") announced today that it received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") indicating that because the Company had not yet filed its Form 10-Q for the quarterly period ended March 31, 2025 (the "Form 10-Q"), the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule") requiring Nasdaq-listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the "SEC").

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

PLEASANTON, Calif. , May 16, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced today that its Board of Directors has initiated a process to explore strategic alternatives, including a sale, merger or similar transaction involving the Company, to maximize shareholder value.

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

Leveraging the Company's System-on-a-Chip (SoC), the clinical study results are another significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure device PLEASANTON, Calif. , April 22, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced positive results of its most recent 81-participant blood pressure clinical study.

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

Upgrades Also Include Integration with Apple Health, Manual Post-Workout Logging PLEASANTON, Calif. , March 10, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology and maker of the Evie Ring, today announced a series of new data personalization, trend tracking and integration features on the ring's companion app that expand support for women's wellness journeys.

Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey

Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

New proprietary RF hardware delivers significantly enhanced signal fidelity PLEASANTON, Calif. , Feb. 4, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable.

Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device

Movano Health Launches EvieAI Virtual Wellness Assistant

Newest Evie Ring feature is the first medical journal trained AI companion in a wearable PLEASANTON, Calif. , Jan. 8, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals.

Movano Health Launches EvieAI Virtual Wellness Assistant

Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

PLEASANTON, Calif. , Jan. 2, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of directors with the addition of Dr. Shaheen Wirk, a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research.

Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors

See News Rankings

Charts implemented using Lightweight Charts™